Discovery and Optimization of a Series of Vinyl Sulfoximine-Based Analogues as Potent Nrf2 Activators for the Treatment of Multiple SclerosisYoowon Kim(Yonsei University), Ki Duk Park(University of Science and Technology)Journal of Medicinal ChemistrySeptember 26, 202410.1021/acs.jmedchem.4c01907Cited by 12SaveCiteExport RISWatch citationsRelated PapersTargeting the CaVα–CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy|Pain|2019|44